Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Procter & Gamble Co (PG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Procter & Gamble Co — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Procter & Gamble Co trades at $148.39 (market cap $355.69B). The key difference: Procter & Gamble Co is far larger — about 79.2× ACADIA Pharmaceuticals Inc.'s market cap, and Procter & Gamble Co pays a 2.79% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | PG | |
|---|---|---|
Market Cap | $4.49B | $355.69B |
Sector | Health | Consumer Staples |
52-Week High | $28.06 | $167.18 |
52-Week Low | $20.06 | $138.10 |
Enterprise Value | $3.69B | $381.17B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Procter & Gamble (PG) trades at $152.75, up 2.3% recently, with a bullish technical signal and strong support near $151. The company reported consistent earnings beats, with Q1 2026 EPS of $1.59 exceeding the $1.56 estimate, and maintains robust profitability with a 19.16% net income margin. Recent developments include a new WNBA partnership and a $1.09 dividend payment scheduled for May 2026.
PG offers stable growth and income appeal, supported by a 55.77% analyst buy rating and a $159.88 consensus price target. Risks include premium valuation multiples and soft demand concerns. The stock's resilience in volatile markets positions it as a defensive holding, though margin pressures from inflation remain a watchpoint.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
